Tags

Type your tag names separated by a space and hit enter

Severe Neurologic Complications of SARS-CoV-2.
Curr Treat Options Neurol. 2021; 23(5):14.CT

Abstract

Purpose of Review

This review presents an overview of the known neurocritical care complications of severe acute respiratory virus 2 (SARS-CoV-2). We present readers with a review of the literature of severe neurologic complications of SARS-CoV-2 and cases from our institution to illustrate these conditions.

Recent Findings

Neurologic manifestations are being increasingly recognized in the literature. Some patients can have severe neurologic manifestations, though the true prevalence is unknown.

Summary

Severe neurologic complications of COVID-19 include large vessel occlusion ischemic stroke, intracranial hemorrhage, encephalitis, myelitis, Guillain-Barre syndrome, status epilepticus, posterior reversible encephalopathy syndrome, and hypoxic-ischemic encephalopathy. These conditions can manifest in COVID-19 patients even in the absence of risk factors and must be promptly identified as they can have a high mortality if left untreated.

Authors+Show Affiliations

Department of Neurology, 1 Gustave L. Levy Place, Box 1136, New York, NY 10029 USA.Department of Neurology, 1 Gustave L. Levy Place, Box 1136, New York, NY 10029 USA. Department of Neurosurgery, The Mount Sinai Hospital, 1 Gustave L. Levy Place, Box 1136, New York, NY 10029 USA.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

33814894

Citation

Sisniega, Daniella C., and Alexandra S. Reynolds. "Severe Neurologic Complications of SARS-CoV-2." Current Treatment Options in Neurology, vol. 23, no. 5, 2021, p. 14.
Sisniega DC, Reynolds AS. Severe Neurologic Complications of SARS-CoV-2. Curr Treat Options Neurol. 2021;23(5):14.
Sisniega, D. C., & Reynolds, A. S. (2021). Severe Neurologic Complications of SARS-CoV-2. Current Treatment Options in Neurology, 23(5), 14. https://doi.org/10.1007/s11940-021-00669-1
Sisniega DC, Reynolds AS. Severe Neurologic Complications of SARS-CoV-2. Curr Treat Options Neurol. 2021;23(5):14. PubMed PMID: 33814894.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Severe Neurologic Complications of SARS-CoV-2. AU - Sisniega,Daniella C, AU - Reynolds,Alexandra S, Y1 - 2021/03/31/ PY - 2021/02/22/accepted PY - 2021/4/5/entrez PY - 2021/4/6/pubmed PY - 2021/4/6/medline KW - COVID-19 related stroke KW - Neurological complications of COVID-19 KW - Seizure SP - 14 EP - 14 JF - Current treatment options in neurology JO - Curr Treat Options Neurol VL - 23 IS - 5 N2 - Purpose of Review: This review presents an overview of the known neurocritical care complications of severe acute respiratory virus 2 (SARS-CoV-2). We present readers with a review of the literature of severe neurologic complications of SARS-CoV-2 and cases from our institution to illustrate these conditions. Recent Findings: Neurologic manifestations are being increasingly recognized in the literature. Some patients can have severe neurologic manifestations, though the true prevalence is unknown. Summary: Severe neurologic complications of COVID-19 include large vessel occlusion ischemic stroke, intracranial hemorrhage, encephalitis, myelitis, Guillain-Barre syndrome, status epilepticus, posterior reversible encephalopathy syndrome, and hypoxic-ischemic encephalopathy. These conditions can manifest in COVID-19 patients even in the absence of risk factors and must be promptly identified as they can have a high mortality if left untreated. SN - 1092-8480 UR - https://www.unboundmedicine.com/medline/citation/33814894/Severe_Neurologic_Complications_of_SARS-CoV-2. L2 - https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33814894/ DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.